Advertisement

Topics

Amgen, Novartis and Banner Discontinue CNP520 in AD

03:42 EDT 12 Jul 2019 | Contract Pharma

An assessment of data identified worsening in some measures of cognitive function

Original Article: Amgen, Novartis and Banner Discontinue CNP520 in AD

NEXT ARTICLE

More From BioPortfolio on "Amgen, Novartis and Banner Discontinue CNP520 in AD"

Advertisement
Quick Search
Advertisement
Advertisement